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Risk of peritonitis and technique failure by CAPD connection tech.
nique: A national study. Peritonitis has been a leading complication of
long-term therapy with continuous ambulatory peritoneal dialysis
(CAPD). This study was designed to evaluate the risk of peritonitis and
technique failure according to the initial CAPD connection technique.
Patients from all U.S. facilities starting CAPD therapy at home between
January 1 and June 30, 1989 were followed for up to 21 months on the
initial CAPD connection technique to change in technique or dialytic
modality, to transplantation, death or loss to follow-up. Patients were
grouped into standard connection techniques (SCT) (N = 1,133), Y-set
(N = 1,067), standard UV set (N = 916) and 0-set (N = 167). The time
to first peritonitis episode was analyzed actuarially and by using the
Cox proportional hazards model which adjusted for age, sex, race,
cause of ESRD, CAPD program size and ESRD therapy prior to CAPD.
Peritonitis occurred on average at 9.0 month intervals with SCT, 15.0
months with Y-set, 13.4 with standard UV and 9.4 with 0-set. The
relative risk (RR by Cox analysis) of first peritonitis compared to SCT
was 0.60 (40% lower) for the Y-set (P < 0.01), 0.75 for standard UV (P
< 0.01), and similar to SCT (RR = 0.96) for the 0-set (NS), all else
being equal. Analysis time to second (N = 1,271) peritonitis episode
gave similar results as did analysis of time to CAPD technique failure.
Significantly higher RR of peritonitis and technique failure was ob-
served for younger and black patients. These findings suggest the
utilization of connection techniques with superior results.
Continuous ambulatory peritoneal dialysis (CAPD) is an
established treatment for patients with end-stage renal disease
(ESRD), and in the U.S. 14,800 patients (12.7% of all dialysis
patients) were being treated by CAPD at the end of 1989 [1].
This number has continued to increase in recent years as did
that for all dialysis patients, and the number for CAPD patients
has reached 17,000 at the end of 1990, while that for all
peritoneal dialysis patients exceeds 20,000 Iii]. The major
limitation of CAPD has been the problem of peritonitis, the
most common reason for hospitalization [21 and for discontin-
uation of this form of dialysis [2, 3]. Peritonitis is most com-
monly secondary to the introduction of bacteria during dialysis
bag-tubing connection (usually 4 times daily) or to infection
along the peritoneal catheter (exit site or "tunnel" infection).
Several different connection techniques have been in use, and
single and multicenter studies of peritonitis rates have com-
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pared various connection techniques with the standard manual
system.
The present study examines a national census of patients who
started CAPD in early 1989 to determine the U.S. experience
with CAPD and the risk of peritonitis and technique failure
associated with various connection techniques after adjustment
for a variety of factors.
Methods
Data sources
All data for this study come from the United States Renal
Data System (USRDS) [4], and the specific clinical CAPD data
were collected in a USRDS Special Study on CAPD peritonitis.
This study sampled essentially all CAPD patients completing
self-care training during the first six months of 1989. These
patients were followed for varying lengths of time from first
CAPD treatment at home to change in technique, change in
modality of care, death, or the end of the reporting period.
Follow-up ended between May 15, 1990 and November 20,
1990, since abstraction of patient records occurred between
these dates.
The Peritonitis Special Study data were reported by individ-
ual dialysis units using special data collection forms; the forms
used were published with the USRDS 1990 Annual Data Report
[4]. Forms were submitted by the dialysis facilities to the local
ESRD Network office and were forwarded via the Health
Standards and Quality Bureau of the Health Care Financing
Administration (HCFA) to the USRDS for data entry. Patient
demographic and other historical data from the USRDS data
base were merged with the data collected on the USRDS
"Special Study Form for Peritonitis in CAPD Patients" to
obtain complete records on all patients studied.
Selection of patients
All patients in the United States who started home CAPD for
the first time between January 1, 1989 and June 30, 1989 were
eligible to be included in this study. To limit the respondent
burden for large CAPD programs, dialysis units were instructed
to provide data for all patients who initiated CAPD for the first
time, up to a maximum requirement of 14 patients. In fact, less
than five percent of units had more than 14 patients submitting
the requested first 14 eligible patients.
967
968 Port et a!: CAPD peritonitis rates and risks
Dialysis units were identified for this study by reviewing the
1989 Facility Survey. This reports for ESRD facilities both
activities during 1989 and the status of all treated patients on
December 31, 1989 [11. Units were included in this study if they
indicated any CAPD self-care training, any CAPD patients on
December 31, 1989, or if they were certified by HCFA to do
CAPD self-care training. All such units were mailed CAPD
Special Study forms and detailed instructions. To ensure com-
pliance, the ESRD Networks monitored the submission of
completed forms by all facilities. This process achieved a
response rate by dialysis units of almost 100%.
Calculation of risk periods and peritonitis episodes
For each patient the study period begins on the date the
patient started CAPD at home. The study stop date for individ-
ual patients was determined by the date on which the patient's
medical records were abstracted (May 15 to November 20,
1990) or, whichever occurred earlier, the date of switch to a
different CAPD connection technique, or to a different treat-
ment modality (other PD, hemodialysis or renal transplant), or
of loss to follow-up or death. Thus, for a patient who continued
using the same CAPD connection technique when the medical
records were abstracted, the study ended at the study form
completion date, for a follow-up duration which ranged from
10.5 to 21 months.
All peritonitis episodes were considered, with the following
exceptions: (1) Peritonitis episodes detected within three days
of the home CAPD start date were excluded, as they may have
actually developed prior to the first CAPD treatment at home.
(2) Subsequent peritonitis episodes were not counted as distinct
episodes if they were identified as relapses in the medical
records, or if they occurred within four weeks of the start of the
previous episode and had the same organism or no growth
identified in the culture. Peritonitis episodes that were detected
within three or fewer days after the study stop date were
included in the analysis.
For all analyses CAPD techniques were grouped as: (1)
"standard" including spike with and without Luer lock or assist
and the sterile connecting device, (2) disconnect "0-set"
system, (3) disconnect "Y-set" system with and without use of
antiseptic instillation, and (4) "standard UV" system excluding
the UV systems utilized in some disconnect techniques which
are counted under the 0-set or Y-set. Unspecified connection
techniques accounted for less than two percent of cases and are
excluded from these analyses.
Calculation of peritonitis rates
This peritonitis rate was calculated counting all peritonitis
episodes per time at risk (that is, each patient's days of the
study period). In agreement with most reports, the reciprocal of
this peritonitis rate is reported as the average time interval per
episode. Relapses of peritonitis, as defined above, were not
counted. Average days per episode were calculated and re-
ported in months per episode for subgroups of patients, partic-
ularly by connection technique.
Actuarial analysis of remaining peritonitis-free
Time from start of CAPD at home to first peritonitis episode
was analyzed as the cumulative time without peritonitis. This
variable was measured in days, from the day a patient started
CAPD at home to the day of the first episode of peritonitis, or
to the date of change in status or end of follow-up. Similarly,
time from first peritonitis to second peritonitis episode was
analyzed for all patients who developed a peritonitis episode
during the period of study.
This actuarial analysis was expanded using the Cox propor-
tional hazards model [5] to compare the relative risk (RR) of
remaining peritonitis free by the four connection techniques
with adjustment for the following covariates: patient age in 1989
(5 age groups), patient race (white, black, other), cause of
ESRD (diabetes, hypertension, glomerulonephritis, cystic kid-
ney disease, other), CAPD program size (1 to 6, 7 to 20 and
> 20 patients enrolled in 1989) and duration of ESRD therapy
prior to going home on CAPD (< 1 month, 1 to 3 and > 3
months). Additionally, this analysis provided estimates of rel-
ative risk of a first peritonitis episode for each covariate, when
adjusting for connection technique and all other covariates. The
same methodology was utilized in a Cox proportional hazards
analysis to estimate the relative risk of developing a second
episode of peritonitis calculated in days from first peritonitis
episode.
Technique failure analysis
Technique survival was analyzed by actuarial technique and
the relative risk of technique failure by the Cox proportional
hazards model. Any change in connection technique or change
in dialytic modality was counted as technique failure. Patients
dying or receiving a renal transplant were censored on that
date. Additionally, the impact of defining death as technique
failure rather than censoring event was analyzed.
For all analyses, statistical significance applied toP values of
0.05 or less.
Results
Patient characteristics
Valid data forms were submitted on 3,366 CAPD patients
who started CAPD at home for the first time between January 1,
1989 and June 30, 1989. A total of 706 CAPD units submitted
data forms. The number of patients per unit ranged from one to
23. For 74% of these patients CAPD was the first treatment
modality. Of the remainder, 3% had a prior renal transplant,
while 17% had previously used hemodialysis without trans-
plant, and 6% of patients had other or unknown reporting of
prior treatment status.
Linking the study forms to the USRDS data base on Medi-
care patients was successful in 94 percent of patients; the
remaining 6% likely had insurance coverage other than Medi-
care. This agrees with other estimates that 93% of ESRD
patients are covered by Medicare [lb For patients matched
with USRDS files the gender, race and primary cause of ESRD
can be described. As shown in Table 1, age, race and diagnosis
distributions vary somewhat by connection technique. Through
statistical methods, adjustments are made in subsequent anal-
yses for the observed differences in these distributions.
Connection and catheter factors
The distribution of connection techniques among study pa-
tients is shown in Figure 1. The groups of Standard, UV and
Y-set accounted for 27 to 34 percent of first techniques used at
50% - Percentages add to 100% I
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Fig. 1. Percent distribution of CAPD
connection techniques in the study sample (N
= 3,344, January-June 1989).
Table 1. Characteristics of the CAPD peritonitis study population by
CAPD techniquea
Standard
Standard Y-set UV 0-set
Nb I,133 1,067 916 167
Median age 55 45 59 43
% Male 54 53 53 57
Race %
Black 22 25 17 30
White 75 71 79 66
Other 3 4 4 4
Cause of ESRD %
Diabetes 30 28 41 26
Hypertension 23 19 22 26
Glomerulonephritis 19 20 14 21
Other causes 15 19 12 15
Unknown/missing 13 15 12 12
a Percentages calculated above do not include 'missing' observations
(<7%).
b Other techniques not shown (N = 61)
home, whereas the 0-set and other techniques contributed only
5% and 2%, respectively. The use of an antiseptic agent in the
connection tubing was recorded in 93 percent of 0-sets and in 7
and 9% of standard and Y-sets, respectively.
Peritonitis rates
Assessment ofaverage months per episode (inverse peritoni-
tis rates), counting days at risk and all peritonitis episodes
(except relapses as defined above) revealed the numbers shown
in Table 2. The total of 3,109 patients excludes those with other
connection techniques, prior transplant and more than 10 years
of prior ESRD therapy. The latter were excluded because of the
potential effect of immmunosuppressive agents on the peritoni-
tis risk and the questionable accuracy of USRDS data (such as
cause of ESRD) before 1979. The standard set had a peritonitis
rate indicator of nine months/episode while the Y-set had a rate
of 15 months/episode, or 67% longer intervals on average (P <
0.01). The rate ratios for Y/SCT and UV/SCT were essentially
unchanged when this analysis was repeated counting presumed
relapses as new peritonitis episodes.
Table 2. Peritonitis rates by technique, new CAPD patients, 1989a
Technique
(Patient days)C
Peritonitis rate months'
First Subsequent Total
Standard (194K) 11.4 6.3 9.0
Y-set (240 K) 20.6 8.2 15.0
0-set (33 K) 13.0 6.2 9.4
Standard UV (191 K) 16.4 9.1 13.4
a N = 3,188
b Months per episode, first and subsequent peritonitis
C Patient days in thousands (K)
Probability of remaining peritonitis-free
The time in days from starting CAPD at home to first episode
of peritonitis or censoring was analyzed as the actuarial prob-
ability percentages of remaining on the same connection tech-
nique without peritonitis. Figure 2 shows the actuarial curves
for the four types of connection techniques during the 1.5 years
of study. The curves are highest for the Y-set, lowest for the
standard and 0-sets, and intermediate for the standard UV-set
technique. At one year the fraction remaining without peritoni-
tis was 56% for the Y-set, 49% for the UV-set, 40% for the 0-set
and 38% for the standard sets. The odds ratio of first episode of
peritonitis at one year relative to the standard set (1.0) was 0.48
for the Y-set (that is, odds are reduced by 52%), 0.64 for the
standard UV-set, and 0.92 for the 0-set.
For patients developing a first episode of peritonitis the
probability of subsequently remaining peritonitis-free or the
time to second episode was analyzed in the same fashion.
Figure 3 shows the actuarial probability of remaining without a
second peritonitis after the first episode of peritonitis for each
connection technique group. The Y-set and the standard UV set
have higher percentages of not developing peritonitis than do
the standard and the 0-sets. At one year, the odds ratio of
second episode of peritonitis was 0.67 (that is, 33% lower) for
the standard UV-set and 0.65 for the Y-set when compared to
the standard set.
Analysis of the relative risk of first peritonitis according to
connection technique by using the Cox proportional hazards
C
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model confirmed these findings. When adjusted for age, race,
primary disease, center size and months of prior ESRD ther-
apy, the relative risk of first peritonitis was significantly lower
for the Y-set (RR = 0.60, P < 0.01) and for the standard UV set
(RR = 0.75, P < 0.01) than for the reference (1.0) of the
standard set (Fig. 4). The difference in RR between Y-set and
standard UV set was also statistically significant (P < 0.01).
Results for the 0-set were not significantly different (RR =0.96)
from those with the standard set. Results for the other covari-
ates are also shown in Table 3. Patients aged 40 to 59 years had
a 16 percent lower relative risk of first peritonitis (RR = 0.84)
than patients aged 20 to 39 years (P 0.02). Black patients had
a 61% higher risk of first peritonitis than White patients (RR =
1.61, P < 0.01). Diabetic patients had a relative risk of 1.20
compared to patients with ESRD due to glomerulonephritis (P
= 0.03). Size of the CAPD program was not significantly
associated with peritonitis risk, but a trend toward lower risk
for larger programs existed, all else being equal. Longer dura-
tion of prior ESRD therapy was associated with a higher risk of
peritonitis which did not reach statistical significance. In a
separate Cox analysis limited to patients using the Y-set, those
with reported use of an antiseptic had a peritonitis risk not
significantly higher than those without an antiseptic (RR = 1.11,
P = 0.6). Another Cox analysis limited the maximum length of
follow-up to 10.5 months for all patients: All findings on relative
risk of first peritonitis (Table 3) remained essentially unchanged
except for a slightly lower risk associated with diabetes (RR =
1.17, P = 0.07).
Results for the Cox proportional hazards model analysis of
the relative risk of second peritonitis from date of first perito-
nitis (excluding relapses) are also shown in Figure 4. The
relative risk for the Y-set was 0.69 (P < 0.01), for the standard
UV set 0.72 (P < 0.01), and for the 0-set 1.02 (P > 0.1). The
covariates of age, race and diagnosis gave results similar to
those for first peritonitis risk, but the relative risks for these
covariates did not reach statistical significance.
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Fig. 3. Actuarial percent of patients
remaining peritonitis-free after the first
peritonitis in days from first to second
0 50 100 150 200 250 300 350 400 450 500 peritonitis episode by connection technique. N
at start: Y-set = 415, Stand UV = 400, 0-set
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Fig. 4. Relative risk of developing first
peritonitis (from start of CAPD at home) and
second peritonitis (from first peritonitis
episode) in days to event by connection
technique, compared to the standard Sets
using two Cox proportional hazard models.
For adjusted covariates see Table 3. Symbols
are: (1i) RR of first; () RR of second. N of
the first = 2,807, of the second = 1,271.
Table 3. Relative risk of first peritonitis and technique failure by Cox
Proportional Hazards Model, 1989—90
First Technique
peritonitis failure
Covariate N RR P RR P
Connection technique
Standard (ref.) 956 1.00 — 1.00 —
Y-set 876 0.60 <0.01 0.49 <0.01
Standard UV 786 0.75 <0.01 0.73 <0.01
0-set 136 0.96 NS 0.64 <0.01
Other 53 0.68 NS 0.55 <0.05
Age
<20 58 0.99 NS 1.06 NS
20—39 (ref.) 665 1.00 — 1.00
40—59 1,014 0.84 0.02 0.79 <0.01
60—69 626 1.00 NS 0.72 <0.01
70+ 444 1.00 NS 0.77 <0.05
Race
White (ref.) 2,103 1.00 — 1.00 —
Black 615 1.61 <0.01 1.20 <0.05
Other 89 1.08 NS 1.18 NS
Sex
Male (ref.) 1,503 1.00 — 1.00 —
Female 1,304 1.01 NS 0.97 NS
Diagnosis
GN (ref.) 483 1.00 — 1.00 —
Diabetes 936 1.20 0.03 1.12 NS
Hypertension 627 1.09 NS 1.06 NS
Cystic disease 98 1.03 NS 1.82 <0.01
Other 478 0.92 NS 0.91 NS
Missing 185 1.01 NS 0.79 NS
CAPD program size
1-6 215 1.20 NS 1.09 NS
7—20 (ref.) 741 1.00 — 1.00 —
21+ 1,851 0.90 NS 0.77 <0.01
Prior ESRD Rx
<1 month (ref.) 1,143 1.00 — 1.00 —
1—3 months 1,030 1.02 NS 1.11 NS
>3 months 634 1.13 NS 1.19 NS
Technique failure
The actuarial percentage of patients remaining on the same
CAPD connection technique is shown in Figure 5. The Y-set
had the highest percentage with 77% on the same technique at
one year followed by the 0-set (7 1%) and the standard UV-set
(70%), with the standard set having the lowest probability
(6 1%). At one year the odds ratio of technique failure compared
to the standard set (1.0) is 0.46 for the Y-set (that is, 54%
lower), 0.63 for the 0-set, and 0.67 for the standard UV set (P
<0.01 each). When including death as a technique failure, the
fraction of patients remaining on the same technique at one year
is reduced, ranging between 50 and 70% although the order of
actuarial technique survival curves remains unchanged (data
not shown).
When adjusted for age, race, sex, primary cause of ESRD,
CAPD program size and months from onset of ESRD to start of
CAPD, the Cox proportional hazards analysis for technique
failure gave the results shown in Table 3. Compared to the
standard set each of the other three techniques had significantly
lower risks of changing connection technique or dialysis ther-
apy (P < 0.01 for each) and are ranked in the same order as in
the unadjusted actuarial technique survival analysis. The cova-
riates had statistically significant correlations with technique
survival when adjusted for technique used. Older patients (age
> 70 years) had a lower relative risk for technique failure when
censoring for death and a higher risk when including death (RR
= 1.38, P < 0.01, not shown) compared to the age group of 20
to 39 years. These observations are at least in part due to the
higher death rate among older patients. The risk of technique
failure for Black patients was 20% higher than that for White
patients (RR = 1.20, P < 0.05); large CAPD units had a 23%
lower risk than medium size units (RR = 0.77, P < 0.01), and
patients on ESRD therapy more than three months prior to the
start of study had a higher risk (RR = 1.19, P = 0.07) than
patients with less than one month of ESRD therapy before
going home on CAPD.
Description of first peritonitis episode
At the time of first peritonitis 13% of patients had docu-
mented exit site infections and 3% had leakage of peritoneal
dialysate. Three percent of patients developed their first peri-
tonitis during an unrelated hospitalization. First peritonitis
resulted in hospitalization in 31% of patients. For the first
peritonitis episode effluent dialysate culture results were re-
ported in 92% of patients, and showed no growth in 20% of
patients. Gram positive organisms predominated, as shown in
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Figure 6, followed by gram negative infections; fungal cultures
were positive in less than 2% of cases.
Discussion
This study has the advantage of a large sample size. In
addition, it represents a virtual national census of patients new
to CAPD in the time period studied and so describes actual
practice in the U.S. rather than the practice of several large
collaborating research-oriented institutions. This study was
designed to investigate the early course (first 10 to 20 months) of
patients after starting CAPD at home, and thus provides no
information about patients treated with CAPD long-term. Sev-
eral other studies included all prevalent CAPD patients, some
of whom had been on CAPD for long periods of time [6]. Such
differences in study design must be considered when results are
compared. One example is the relatively low frequency of
positive fungal cultures in this study, (less than two percent for
the first (Fig. 6) episode of peritonitis), whereas other studies
report fungal infections in 3 to 15 percent of prevalent (including
long-term) CAPD patients [2, 7].
The overall peritonitis rates observed here are similar to
those described by others for the standard connection tech-
nique. The U.S. CAPD registry showed 9.2 months per perito-
nitis episode in patients trained in 1987, which was nearly
constant for yearly cohorts from 1981 to 1987 [21, and matches
standard connection technique in the present results of 9.0
months for the 1989 cohort. Similarly, the Canadian multicenter
study showed an average of 9.9 months [8}, but the multicenter
study from Italy reported a longer average interval of 13.1
months per episode for 1983 through 1985 [9]. The latter two
studies also present peritonitis rates for the Y-set technique
(Table 4). Compared to the present finding of 15 months, the
Canadian and Italian studies show longer intervals of 20.2 to
21.5 months per episode, respectively, whereas the Canadian
181 and Italian Y-set connection technique [9, 10] commonly
employ an antiseptic, it is rarely used in the U.S. [11, 12].
However, among the 9% of Y-set patients reported to utilize an
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Fig. 5. Actuarial percent of patients
remaining on the initial connection technique
(technique survival) in days since the start of
CAPD at home (deaths and transplants are
censored in this analysis). N at start: Y-set =
1,067, 0-set = 167, Stand UV = 916, Stand =
Time, days since start of CAPO 1,133.
Fig. 6. Percent distribution of peritoneal
dialysate culture results for first peritonitis
episode (N = 1,517).
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Table 4. Comparison of time to first peritonitis episode: Canada,
Italy, U.S.
Technique
Peritonitis-free at 12 months (%)
Churchill et a! Fellin et al USRDS
Standard 27 38 38
Y-set 46 66 56
Odds ratio (Y- 0.43 0.32 0.46
set/Stand)
N(at start) 124 791 2,200a
a Standard and Y-set only
antiseptic, the peritonitis risk was not lower than that of the
remaining Y-set patients. The fact that the present study deals
with the experience of a national census rather than that of
collaborating institutions interested in CAPD research may
explain the better results for the latter.
The actuarial approach to estimating the time to an episode of
peritonitis or probability of remaining peritonitis-free has been
used by others, and the results of this study are similar to those
of the Canadian and Italian multicenter studies [8, 91. Analyzing
the relative risk of developing peritonitis with adjustment for
covariates using the Cox proportional hazards model provides
new insights into the role of covariates and confirms the findings
from the univariate analysis for the connection techniques. The
adjusted relative risk of developing peritonitis is 40 percent
lower for the Y-set and 25 percent lower for the standard UV
set when compared to the standard set (P < 0.01 for each).
Analysis of the relative risk of remaining peritonitis-free after a
first episode of peritonitis (time from first to second episode)
gives very similar results (P <0.01) and provides confirmatory
evidence of the significant correlation of connection technique
and peritonitis risk.
When adjusted for technique and other factors, the signifi-
cantly higher risk of peritonitis among younger adult patients is
intriguing since it was not detected in the CAPD registry [2].
Perhaps lower compliance in younger patients plays a role in
this. The increased risk of peritonitis among Black as compared
to White patients confirms previous reports [2]. This finding,
and the increased technique failure in Blacks, may be among
the reasons why there is a lower utilization of CAPD in Blacks
compared to Whites [2, 13]. The observed increased peritonitis
risk among diabetic patients is consistent with their generally
increased susceptibility to infection. Intraperitoneal use of
insulin theoretically would increase the peritonitis risk, al-
though the U.S. CAPD Registry could not document such an
added risk [21. Whether the increased peritonitis risk among
diabetics explains in part the finding in some studies of greater
mortality among diabetic CAPD patients compared to diabetic
hemodialysis patients [13, 141 deserves further investigation.
The actuarial technique survival analysis showed beneficial
results for the Y-set and intermediate results for the standard
UV set compared to the standard sets, and agrees with the
peritonitis risk analyses. However, this analysis shows for the
0-set a strong benefit for technique survival compared to the
standard sets which could not be shown for peritonitis risk. The
risk for the comparison group in this analysis may be unfairly
high, due to the growing popularity of newer disconnect sets
(0-set and Y-set) which may have caused elective technique
changes from standard connection techniques without neces-
sarily indicating problems with the standard sets. The relatively
high ranking of the 0-set above the UV-set deserves further
study since it is based on a relatively small sample size (N =
167). The results of these actuarial analyses are confirmed by
statistically significant findings in the Cox proportional hazards
analysis. The latter yields several significant findings regarding
other covariates. When adjusted for technique, age, race, sex,
cause of ESRD and duration of prior ESRD, large CAPD
centers had a significantly lower risk of technique failure than
medium size centers. A similar finding for peritonitis risk did
not reach statistical significance. The higher technique failure in
Black than White patients is consistent with the finding for
peritonitis risk by race and deserves further study.
The main technique failure analyses used a definition that is
the same as that employed by others [2] in that death is
censored and not considered a technique failure. Using this
definition, patients over 40 years had a significantly lower risk
of technique failure than those aged 20 to 39 years. This
observation, however, is not significant if death is counted as
technique failure. The analyses of technique survival are par-
ticularly interesting for their corroboration of the corresponding
analysis of peritonitis risk for all connection techniques except
the 0-set.
For the disconnect sets, a sixfold difference was observed in
the number of patients utilizing the Y-set (N 1067) compared
to the 0-set (N = 167). In part this difference may be explained
by the requirement of an intraluminal disinfectant for the 0-set
and associated potential risks of accidental intraperitoneal
instillation [15]. Whereas in Europe and Canada both Y-set and
0-set commonly use a disinfectant [8—10], it is rarely employed
with the Y-set in the U.S. [11].
Although the Cox analysis adjusted for a possible effect of
CAPD program size on peritonitis risk, there remains potential
concern that differential technique selection by better centers
may account for the benefits of certain techniques being utilized
by these centers. To address this concern, adjustments for each
medium size and large center (N = 239) were made, while all
small centers (<5 patients entered) were aggregated into one
cell. While most large centers utilized multiple techniques,
those using a single technique preferred the standard technique
(12%), followed by the Y-set and the standard UV set (9%
each). The Cox proportional hazards analysis was repeated,
stratifying on 239 individual centers with five or more study
cases plus the small center group. This analysis confirmed the
findings of first peritonitis risk compared to standard techniques
for the Y-set (RR 0.57, P < 0.01), for the standard UV set
(RR = 0.72, P < 0.01) and for the 0-set (RR = 0.85, P = NS).
When the cell of centers (less than 5 study patients) was
excluded, the results compared to the standard set were essen-
tially unchanged (RR for Y-set = 0.54, for standard UV set =
0.71, for 0-set = 0.99). Thus, a center effect does not likely
explain the findings of this study.
The selection of patients to utilize certain connection tech-
niques could not be evaluated in the present study and might
have affected some of the results. Should more compliant and
better educated patients be selected to use the Y-set, then the
results could be more related to patient factors than to the
connection device. One may suspect, however, that the 0-set
(requiring instillation of an antiseptic) would be utilized by an
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equally or more selected group of patients, yet their results on
peritonitis risk argue against this hypothesis.
To conclude, this national study on over 3000 ESRD patients
starting CAPD at home in early 1989 revealed large and
statistically significant differences in peritonitis rates and con-
nection technique survival rates by CAPD connection tech-
nique. Patients treated with the Y-set had much better out-
comes, while those treated with the standard UV-set had
intermediate benefits regarding both peritonitis and technique
failure risks. The 0-set technique showed little benefit for
reducing the peritonitis risk over the standard technique. Anal-
yses with multiple adjustments for patient and center effects
confirmed these significant results. Newer connecting devices
have reduced peritonitis rates to levels well below those re-
ported by the National CAPD Registry [2] for 1981 to 1987.
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Note added in proof
The use of intrapentoneal drugs in diabetic and nondiabetic CAPD
patients was associated with an increased relative risk of first peritonitis
(RR = 1.14, P = 0.08 overall). Since diabetics predominated in the
intraperitoneal drug administration, this finding explains in part the
observed increased peritonitis risk among diabetic patients. Reference:
United States Renal Data System, USRDS 1992 Annual Data Report,
Chapter VI, Catheter-related factors and peritonitis risk in CAPD
patients, Bethesda, NIH/NIDDK, August 1992, p. 39—46
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